AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35776749 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical models adjusting for exposure time, covariates, and data augmentation
Number of subjects: 0
Study 35776749 — intervention group
Group type: EXPERIMENTAL
Intervention: Safety endpoint analysis
Number of subjects: 0
Study 35776749 — intervention group
Group type: EXPERIMENTAL
Intervention: Raw data examination
Number of subjects: 0
Study 32976346 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct drive hearing aid with wider bandwidth
Number of subjects: 15
Study 32976346 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct drive hearing aid with 123 Hz cut-off
Number of subjects: 15
Study 32976346 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-band conditions
Number of subjects: 15
Study 33771833 — intervention group
Group type: EXPERIMENTAL
Intervention: MyREADY Transition TM BBD App
Number of subjects: 264
Study 33771833 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 264
Study 33177756 — intervention group
Group type: EXPERIMENTAL
Intervention: Community health worker providing supplementary hypertension‐oriented care including proteinuria assessment by visual assessment of urinary dipstick at the first visit and all subsequent visits when hypertension was detected.
Number of subjects: 30233
Study 33177756 — intervention group
Group type: EXPERIMENTAL
Intervention: Projected annual cost savings if proteinuria testing were restricted to women with hypertension.
Number of subjects: 30233
Study 36346619 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetes
Number of subjects: 38
Study 36346619 — intervention group
Group type: COMPARATOR
Intervention: Non-diabetic (ND)
Number of subjects: 38
Study 33546490 — intervention group
Group type: EXPERIMENTAL
Intervention: Front-of-pack nutrition labelling (FOP-NL) systems
Number of subjects: 0
Study 33546490 — intervention group
Group type: EXPERIMENTAL
Intervention: Easy-to-interpret FOP-NL
Number of subjects: 0
Study 33546490 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational campaigns
Number of subjects: 0
Study 33546490 — intervention group
Group type: EXPERIMENTAL
Intervention: Monitoring strategy
Number of subjects: 0
Study 32365109 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative mood induction
Number of subjects: 165
Study 32365109 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive mood induction
Number of subjects: 165
Study 32365109 — intervention group
Group type: COMPARATOR
Intervention: Neutral mood induction
Number of subjects: 165
Study 34992099 — intervention group
Group type: EXPERIMENTAL
Intervention: Informational SRH text messages on-demand
Number of subjects: 740
Study 34992099 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly texts instructing to study SRH topics
Number of subjects: 740
Study 34992099 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 740
Study 34561781 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing a surgical mask
Number of subjects: 6
Study 34561781 — intervention group
Group type: COMPARATOR
Intervention: Not wearing a surgical mask (unmasked)
Number of subjects: 6
Study 34561781 — intervention group
Group type: EXPERIMENTAL
Intervention: Wearing a surgical mask (sensitivity analysis)
Number of subjects: 6
Study 34561781 — intervention group
Group type: COMPARATOR
Intervention: Not wearing a surgical mask (unmasked, sensitivity analysis)
Number of subjects: 6
Study 35067753 — intervention group
Group type: EXPERIMENTAL
Intervention: FO + D (fish oil plus vitamin D3)
Number of subjects: 111
Study 35067753 — intervention group
Group type: COMPARATOR
Intervention: FO (fish oil)
Number of subjects: 111
Study 35067753 — intervention group
Group type: COMPARATOR
Intervention: CO (corn oil)
Number of subjects: 111
Study 32437191 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured Dyadic Behavior Therapy (SDBT)
Number of subjects: 34
Study 32437191 — intervention group
Group type: COMPARATOR
Intervention: Attention Control (Child-Centered Dyadic Therapy - CCDT)
Number of subjects: 34
Study 32006071 — intervention group
Group type: EXPERIMENTAL
Intervention: Informational flipchart on pelvic floor muscle training (PFMT) and lifestyle advice
Number of subjects: 140
Study 32006071 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 140
Study 34560315 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg/kg of 0.25% levobupivacaine with 5 µg/mL epinephrine
Number of subjects: 24
Study 34560315 — intervention group
Group type: COMPARATOR
Intervention: 1 mg/kg of 0.25% levobupivacaine alone
Number of subjects: 24
Study 34520324 — intervention group
Group type: EXPERIMENTAL
Intervention: Music intervention
Number of subjects: 74
Study 34520324 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 74
Study 33865010 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive stimulation program (10 sessions of 45 min for 10 weeks)
Number of subjects: 29
Study 33865010 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study 33865010 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive stimulation program
Number of subjects: 29
Study 32239091 — intervention group
Group type: EXPERIMENTAL
Intervention: CA125
Number of subjects: 92
Study 32239091 — intervention group
Group type: EXPERIMENTAL
Intervention: HE4
Number of subjects: 92
Study 32239091 — intervention group
Group type: EXPERIMENTAL
Intervention: ROMA index
Number of subjects: 92
Study 32239091 — intervention group
Group type: EXPERIMENTAL
Intervention: IHC markers
Number of subjects: 92
Study 32239091 — intervention group
Group type: EXPERIMENTAL
Intervention: CA125 and HE4
Number of subjects: 92
Study 33852140 — intervention group
Group type: EXPERIMENTAL
Intervention: Evidence-based intervention
Number of subjects: 99
Study 33852140 — intervention group
Group type: EXPERIMENTAL
Intervention: Education/training
Number of subjects: 99
Study 33852140 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice facilitation
Number of subjects: 99
Study 33852140 — intervention group
Group type: EXPERIMENTAL
Intervention: IS/QI elements
Number of subjects: 99
Study 33852140 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized designs
Number of subjects: 99
Study 33852140 — intervention group
Group type: EXPERIMENTAL
Intervention: Complexity of projects
Number of subjects: 99
Study 32581042 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab followed by ipilimumab (Checkmate-064)
Number of subjects: 3
Study 32581042 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab (Checkmate-066)
Number of subjects: 3
Study 32581042 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab, ipilimumab, or both (Checkmate-067)
Number of subjects: 3
Study 32581042 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy (Checkmate-064)
Number of subjects: 3
Study 34384772 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-step GDM screening
Number of subjects: 23792
Study 34384772 — intervention group
Group type: COMPARATOR
Intervention: 2-step GDM screening
Number of subjects: 23792
Study 32998110 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-min session of moderate-intensity aerobic exercise
Number of subjects: 100
Study 32998110 — intervention group
Group type: COMPARATOR
Intervention: Control group (watched a running/exercise-related video)
Number of subjects: 100
Study 32998110 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute aerobic exercise in children with LD
Number of subjects: 100
Study 34491805 — intervention group
Group type: EXPERIMENTAL
Intervention: SCTA01 (5 mg/kg)
Number of subjects: 33
Study 34491805 — intervention group
Group type: EXPERIMENTAL
Intervention: SCTA01 (15 mg/kg)
Number of subjects: 33
Study 34491805 — intervention group
Group type: EXPERIMENTAL
Intervention: SCTA01 (30 mg/kg)
Number of subjects: 33
Study 34491805 — intervention group
Group type: EXPERIMENTAL
Intervention: SCTA01 (50 mg/kg)
Number of subjects: 33
Study 34491805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study 34491805 — intervention group
Group type: EXPERIMENTAL
Intervention: SCTA01 (5 to 50 mg/kg)
Number of subjects: 33
Study 34491805 — intervention group
Group type: EXPERIMENTAL
Intervention: SCTA01
Number of subjects: 33
Study 32769744 — intervention group
Group type: EXPERIMENTAL
Intervention: Inferior mesenteric artery low ligation
Number of subjects: 168
Study 32769744 — intervention group
Group type: COMPARATOR
Intervention: Inferior mesenteric artery preservation
Number of subjects: 168
Study 34546187 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery performed less than 7 days after fracture
Number of subjects: 184
Study 34546187 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed reduction and percutaneous pinning performed more than 7 days after injury
Number of subjects: 184
Study 34340251 — intervention group
Group type: EXPERIMENTAL
Intervention: suvorexant 10-20 mg
Number of subjects: 285
Study 34340251 — intervention group
Group type: EXPERIMENTAL
Intervention: suvorexant
Number of subjects: 285
Study 34340251 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 285
Study 34371813 — intervention group
Group type: EXPERIMENTAL
Intervention: CS‐RT+CrM (n = 8)
Number of subjects: 23
Study 34371813 — intervention group
Group type: EXPERIMENTAL
Intervention: CS‐RT (n = 8)
Number of subjects: 23
Study 34371813 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 7)
Number of subjects: 23
Study 32346816 — intervention group
Group type: EXPERIMENTAL
Intervention: Paper-based EQ-5D-5L
Number of subjects: 0
Study 32346816 — intervention group
Group type: COMPARATOR
Intervention: Electronic modes (handheld, tablet, IVR, web)
Number of subjects: 0
Study 35810600 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 226
Study 35810600 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga
Number of subjects: 226
Study 35810600 — intervention group
Group type: EXPERIMENTAL
Intervention: Preference match
Number of subjects: 226
Study 34464973 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiotepa-based immunochemotherapy (TIER) regimen including thiotepa 50 mg/m2, ifosfamide, etoposide, and rituximab for 2 cycles.
Number of subjects: 27
Study 34464973 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiotepa-based immunochemotherapy (TIER) followed by autologous stem cell transplantation (ASCT) consolidation.
Number of subjects: 27
Study 32162949 — intervention group
Group type: EXPERIMENTAL
Intervention: Male officer using force
Number of subjects: 452
Study 32162949 — intervention group
Group type: EXPERIMENTAL
Intervention: Female officer using force
Number of subjects: 452
Study 32162949 — intervention group
Group type: EXPERIMENTAL
Intervention: Officers using force
Number of subjects: 452
Study 32162949 — intervention group
Group type: COMPARATOR
Intervention: Officers not using force
Number of subjects: 452
Study 33946024 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral stair walking training + traditional physiotherapy (15 min each)
Number of subjects: 24
Study 33946024 — intervention group
Group type: COMPARATOR
Intervention: Traditional physiotherapy (30 min)
Number of subjects: 24
Study 32187079 — intervention group
Group type: EXPERIMENTAL
Intervention: Superiority trials
Number of subjects: 0
Study 32187079 — intervention group
Group type: EXPERIMENTAL
Intervention: Equivalence trials
Number of subjects: 0
Study 32187079 — intervention group
Group type: EXPERIMENTAL
Intervention: Methodological differences
Number of subjects: 0
Study 35174789 — intervention group
Group type: EXPERIMENTAL
Intervention: Grade 4 hemorrhoids patients
Number of subjects: 51
Study 35174789 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 51
Study 34016554 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative carbohydrate loading (2 carbohydrate drinks: 1 the night before and another 3 hours prior to surgery)
Number of subjects: 134
Study 34016554 — intervention group
Group type: COMPARATOR
Intervention: Standard management (nothing by mouth after midnight prior to surgery)
Number of subjects: 134
Study 32383146 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) at 10 g kg‐1
Number of subjects: 90
Study 32383146 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape seed extract (GSE) at 50 g kg‐1
Number of subjects: 90
Study 32383146 — intervention group
Group type: COMPARATOR
Intervention: Control group (0 g kg‐1 GSE)
Number of subjects: 90
Study 35471480 — intervention group
Group type: EXPERIMENTAL
Intervention: Low molecular weight heparin (LMWH)
Number of subjects: 123
Study 35191331 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-management rehabilitation intervention
Number of subjects: 151
Study 35191331 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 151
Study 33486496 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone for 7 days
Number of subjects: 86
Study 33486496 — intervention group
Group type: COMPARATOR
Intervention: Control group (no methylprednisolone)
Number of subjects: 86
Study 33203008 — intervention group
Group type: EXPERIMENTAL
Intervention: FiberBind
Number of subjects: 18
Study 33203008 — intervention group
Group type: EXPERIMENTAL
Intervention: RG‐I
Number of subjects: 18
Study 33203008 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 18
Study 36007481 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person follow-up
Number of subjects: 208
Study 36007481 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone follow-up
Number of subjects: 208
Study 36007481 — intervention group
Group type: EXPERIMENTAL
Intervention: Text message follow-up
Number of subjects: 208
Study 34967883 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (20 mg/kg every 6 months)
Number of subjects: 3936
Study 34967883 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3936
Study 34967883 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (for children in the shortest quartile of baseline height)
Number of subjects: 3936
Study 34967883 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for children in the shortest quartile of baseline height)
Number of subjects: 3936
Study 35706460 — intervention group
Group type: EXPERIMENTAL
Intervention: Green tea consumption for 6 weeks
Number of subjects: 30
Study 35706460 — intervention group
Group type: COMPARATOR
Intervention: Phase 1 periodontal treatment (scaling and root planning)
Number of subjects: 30
Study 32841846 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 h of bright light (10,000 lux) exposure
Number of subjects: 30
Study 32841846 — intervention group
Group type: COMPARATOR
Intervention: 1 h of dim light (<300 lux) exposure
Number of subjects: 30
Study 35956366 — intervention group
Group type: EXPERIMENTAL
Intervention: WB+KFsug + kiwifruit organic acids (WB+KFsug+OA)
Number of subjects: 9
Study 33555464 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 33
Study 33555464 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 33
Study 33555464 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 33
Study 32716280 — intervention group
Group type: EXPERIMENTAL
Intervention: MedBIKE™ high-intensity interval training
Number of subjects: 10
Study 32886532 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic locomotor training
Number of subjects: 16
Study 32886532 — intervention group
Group type: COMPARATOR
Intervention: Activity-based intervention
Number of subjects: 16
Study 32351156 — intervention group
Group type: EXPERIMENTAL
Intervention: Eye drop booklet
Number of subjects: 370
Study 32351156 — intervention group
Group type: COMPARATOR
Intervention: No eye drop booklet (control group)
Number of subjects: 370
Study 34813505 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunotherapy (OIT)
Number of subjects: 12
Study 34379442 — intervention group
Group type: EXPERIMENTAL
Intervention: Hippocampal avoidance-prophylactic cranial irradiation (HA-PCI)
Number of subjects: 150
Study 34379442 — intervention group
Group type: COMPARATOR
Intervention: Standard prophylactic cranial irradiation (PCI; 25 Gy in 10 fractions)
Number of subjects: 150
Study 34379442 — intervention group
Group type: EXPERIMENTAL
Intervention: HA-PCI
Number of subjects: 150
Study 34379442 — intervention group
Group type: COMPARATOR
Intervention: PCI
Number of subjects: 150
Study 32347899 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix acetate (120 mg, 2 subcutaneous injections)
Number of subjects: 52
Study 32347899 — intervention group
Group type: COMPARATOR
Intervention: Placebo (equal volume to degarelix)
Number of subjects: 52
Study 32347899 — intervention group
Group type: EXPERIMENTAL
Intervention: Degarelix acetate
Number of subjects: 52
Study 35689985 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin intranasally
Number of subjects: 61
Study 35689985 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 32340974 — intervention group
Group type: EXPERIMENTAL
Intervention: Blockchain-based data management system for clinical trials
Number of subjects: 0
Study 34340135 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 1: no/low maltreatment, low trauma
Number of subjects: 96
Study 34340135 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 2: moderate physical and emotional abuse, moderate trauma
Number of subjects: 96
Study 34340135 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 3: moderate-severe maltreatment, low trauma
Number of subjects: 96
Study 34340135 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster 4: severe maltreatment, high trauma
Number of subjects: 96
Study 35034024 — intervention group
Group type: EXPERIMENTAL
Intervention: REACT (renal autologous cell therapy) administered via direct kidney parenchymal injection, 2 injections 6 months apart, with computed tomography guidance.
Number of subjects: 83
Study 35034024 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (deferred treatment group) for 12 months before crossing over to receive REACT.
Number of subjects: 83
Study 35034024 — intervention group
Group type: EXPERIMENTAL
Intervention: REACT (renal autologous cell therapy)
Number of subjects: 83
Study 32974775 — intervention group
Group type: COMPARATOR
Intervention: Coronally advanced flap (CAF)
Number of subjects: 48
Study 32974775 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronally advanced flap + connective tissue graft (CAF + CTG)
Number of subjects: 48
Study 35040392 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger assortments of choices
Number of subjects: 3549
Study 34402076 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure irrigation (NPI) at -5 kPa
Number of subjects: 0
Study 34402076 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure irrigation (NPI) at -10 kPa
Number of subjects: 0
Study 34402076 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative pressure irrigation (NPI) at -15 kPa
Number of subjects: 0
Study 34402076 — intervention group
Group type: COMPARATOR
Intervention: Conventional irrigation (CK)
Number of subjects: 0
Study 32341386 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor incense burning (self-reported use ≥ weekly over the past 5 years)
Number of subjects: 515
Study 32341386 — intervention group
Group type: EXPERIMENTAL
Intervention: Indoor incense burning
Number of subjects: 515
Study 34740676 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial Incentives (FIM)
Number of subjects: 0
Study 34740676 — intervention group
Group type: EXPERIMENTAL
Intervention: Campaign (CAM)
Number of subjects: 0
Study 34740676 — intervention group
Group type: COMPARATOR
Intervention: No intervention (MCM)
Number of subjects: 0
Study 33933130 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced implementation strategy
Number of subjects: 621
Study 33933130 — intervention group
Group type: COMPARATOR
Intervention: Basic implementation strategy
Number of subjects: 621
Study 32671948 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation at a dose of 1.5 × 10^8 cfu/kg in heat-stressed broilers.
Number of subjects: 180
Study 32671948 — intervention group
Group type: COMPARATOR
Intervention: Basal diet without probiotic in heat-stressed broilers (Control).
Number of subjects: 180
Study 32671948 — intervention group
Group type: COMPARATOR
Intervention: Thermoneutral conditions with basal diet (Control).
Number of subjects: 180
Study 34406877 — intervention group
Group type: EXPERIMENTAL
Intervention: ID-HWS1000
Number of subjects: 30
Study 34406877 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 32145739 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral intervention (working memory training, biofeedback and relaxation training, episodic future thinking training) over an 8-week period
Number of subjects: 94
Study 32145739 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 94
Study 36212437 — intervention group
Group type: EXPERIMENTAL
Intervention: Zaltoprofen (480 mg/day) for 48 weeks
Number of subjects: 41
Study 36212437 — intervention group
Group type: COMPARATOR
Intervention: Placebo (similar dosages without zaltoprofen) for 48 weeks
Number of subjects: 41
Study 32899368 — intervention group
Group type: EXPERIMENTAL
Intervention: acute treatment (wearing a mouthguard)
Number of subjects: 23
Study 32899368 — intervention group
Group type: EXPERIMENTAL
Intervention: repeated treatments (8 weeks follow‐up)
Number of subjects: 23
Study 33565827 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted rhinoplasty
Number of subjects: 50
Study 33565827 — intervention group
Group type: COMPARATOR
Intervention: Classic rhinoplasty
Number of subjects: 50
Study 35390540 — intervention group
Group type: EXPERIMENTAL
Intervention: Sociodrama-based communication enhancement program
Number of subjects: 34
Study 35390540 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 34
Study 34486302 — intervention group
Group type: EXPERIMENTAL
Intervention: Milling process (T1, T2)
Number of subjects: 0
Study 34486302 — intervention group
Group type: EXPERIMENTAL
Intervention: Reagent washing (T3, T4, T5, T6, T7)
Number of subjects: 0
Study 34486302 — intervention group
Group type: COMPARATOR
Intervention: Non-processed grains (Control T9)
Number of subjects: 0
Study 34486302 — intervention group
Group type: EXPERIMENTAL
Intervention: Alkaline solution washing (T4)
Number of subjects: 0
Study 35089874 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management program plus routine postoperative care
Number of subjects: 95
Study 35089874 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative care only
Number of subjects: 95